Poster Topical Area: Sports Nutrition

Location: Auditorium

Poster Board Number: 252

P25-022 - Dietary Supplements (DS) that Claim to Manage Pain in the Dietary Supplement Label Database (DSLD)

Sunday, Jun 10
8:00 AM – 6:00 PM

One in four Americans suffers from chronic pain, from headaches to cancer and abdominal to musculoskeletal pain from injury or overexertion. Because chronic pain is widespread, integrative management approaches are always being sought. One possibility is DS.
Objectives: Use the DSLD to identify DS claiming to manage pain, identify ingredients commonly used in these products, identify statements of nutritional support (NS claims) with the term pain and map claims with the ingredients. Finally, assess research supporting the claims.

Methods:
The search and data export options in the DSLD identified product labels containing the word pain in the product name, and claims including the word pain. Only unique products with pain in the product name and NS claims were included in the analysis. Dietary ingredients frequently used in formulating products were identified and data from the top five were selected for final analysis by exporting to Excel 2016. The identified ingredients were mapped to NS claims in products with pain in the product name by using NVivo 11 Pro.

Results:
Of the 46,811 product labels in the DSLD, 33 used pain in the product name and 22 were unique. Of the 1,406 product labels carrying statements with the word pain, 411 were NS claims. The five common ingredients in these 22 and 411 products were turmeric, Boswellia, ginger, Willow bark and bromelain. Although NS claims printed on labels with pain in the product name were soft claims, e.g., relieve pain due to muscle overuse or inflammatory pain reliever, several product names included the terms X or Rx and label designs, which implied they were for treating pain.

Conclusions:
Although DS are used to manage conditions associated with pain, few products in the DSLD carry NS pain claims. The benefits are purported to derive from botanicals in the products. To date, research supporting these claims is preliminary, nonconclusive, or of poor quality to draw conclusions.



Funding Source:

Office of Dietary Supplements, NIH


CoAuthors: Rebecca Costello – Office of Dietary Supplements, NIH; Patricia Deuster – Consortium for Health & Military Performance, Uniformed Services University of the Health Sciences; Laverne Brown – Office of Dietary Supplements, NIH; Johanna Dwyer – Office of Dietary Supplements, NIH

Leila Saldanha


Office of Dietary Supplements, NIH
Rockville, Maryland